NCT02149758

EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Tatyasaheb Kore Dental College · Academic / Other
• Sex: All
• Age: 30 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The hypothesis is that Etoricoxib act as an adjuvant to SRP in alleviating periodontal inflammation by: 1. improving clinical periodontal parameters and, 2. improving the salivary SOD levels.

Conditions

• Cyclooxygenase Two Inhibitors
• Etoricoxib
• Periodontitis
• Superoxide Dismutase
• Saliva

Interventions

Type	Name	Description
DRUG	Etoricoxib

Timeline

• Start date: 2013-01-01
• Primary completion: 2013-06-01
• Completion: 2013-06-01
• First posted: 2014-05-29
• Last updated: 2014-05-29

Locations

1 site across 1 country: India